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Management of airway infections caused by Pseudomonas aeruginosa is a serious clinical challenge, but little
is known about the microbial ecology of airway infections in intubated patients. We analyzed bacterial diversity
in endotracheal aspirates obtained from intubated patients colonized by P. aeruginosa by using 16S rRNA clone
libraries and microarrays (PhyloChip) to determine changes in bacterial community compositions during
antibiotic treatment. Bacterial 16S rRNA genes were absent from aspirates obtained from patients briefly
intubated for elective surgery but were detected by PCR in samples from all patients intubated for longer
periods. Sequencing of 16S rRNA clone libraries demonstrated the presence of many orally, nasally, and
gastrointestinally associated bacteria, including known pathogens, in the lungs of patients colonized with P.
aeruginosa. PhyloChip analysis detected the same organisms and many additional bacterial groups present at
low abundance that were not detected in clone libraries. For each patient, both culture-independent methods
showed that bacterial diversity decreased following the administration of antibiotics, and communities became
dominated by a pulmonary pathogen. P. aeruginosa became the dominant species in six of seven patients
studied, despite treatment of five of these six with antibiotics to which it was sensitive in vitro. Our data
demonstrate that the loss of bacterial diversity under antibiotic selection is highly associated with the
development of pneumonia in ventilated patients colonized with P. aeruginosa. Interestingly, PhyloChip anal-
ysis demonstrated reciprocal changes in abundance between P. aeruginosa and the class Bacilli, suggesting that
these groups may compete for a similar ecological niche and suggesting possible mechanisms through which
the loss of microbial diversity may directly contribute to pathogen selection and persistence.
Mechanically ventilated patients develop bacterial coloniza-
tion of the oropharynx and endotracheal tube within 12 h of
intubation (14, 36). During mechanical ventilation, the endo-
tracheal tube decreases normal airway defenses and allows
microbe-laden oropharyngeal or gastric secretions to be aspi-
rated around the endotracheal tube into the lower airways
(14). The fate of such bacteria in the lungs of intubated pa-
tients is largely unknown. To date, investigations of intubated
patients have used aerobic cultures of either endotracheal se-
cretions or bronchoalveolar lavage (BAL) specimens to deter-
mine the presence of pathogenic bacteria. However, these
techniques determine neither the dominant bacterial species
nor the range of bacterial diversity within the community.
Culture-independent methods provide a more comprehensive
view of bacterial diversity and may be used to evaluate complex
bacterial community dynamics, particularly during antibiotic
therapy.
Culture-independent analyses are typically based on bio-
marker identification. The 16S rRNA gene is the most com-
monly used biomarker for bacterial community studies (44).
Highly conserved regions of the 16S rRNA gene enable am-
plification of this gene from most bacteria with “universal”
PCR primers, while variable regions within this gene permit
discrimination between bacterial types (16). This approach has
been applied successfully to the analysis of environmental (2,
20, 35, 37, 42) and human (18, 26, 28, 29, 38) bacterial com-
munities and has revealed a much broader bacterial diversity
than has traditional culture-based techniques (38). However,
to our knowledge, no previous study has examined the extent
of bacterial diversity within the lungs of intubated patients by
culture-independent methods.
Here, we report the use of two 16S rRNA gene-based cul-
ture-independent methods, clone library sequencing (the cur-
rent “gold standard” in microbial ecology) (1) and a novel
high-density oligonucleotide microarray (PhyloChip) (3). Clone
libraries typically involve sequencing of a few hundred 16S
rRNA genes following PCR amplification; while this strategy
provides great specificity, it may profile only the dominant
organisms of a complex bacterial population, while less-abun-
dant species that may contribute to disease pathogenesis re-
main undetected. For this reason, the PhyloChip approach was
applied in parallel with 16S rRNA clone libraries to determine
changes in the bacterial community composition of the lungs of
intubated patients with hospital-acquired Pseudomonas aerugi-
nosa during antimicrobial treatment.
MATERIALS AND METHODS
Patient selection and sampling protocol. Daily endotracheal aspirates (EAs)
were collected from all intubated patients in the medical, surgical, neurovascular,
and cardiac intensive care units of the University of California at San Francisco
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(UCSF). Daily EA samples were obtained, and all samples were screened by
culture on Difco Pseudomonas isolation agar (Becton Dickinson). Pseudomonas-
positive patients were approached, they gave informed consent, and daily quan-
titative cultures of P. aeruginosa were performed on their respiratory samples.
Blind mini-bronchoalveolar lavage (mini-BAL) was performed with a Combi-
Cath catheter when clinical infection was suspected. The right bronchoalveolar
tree was irrigated with three 20-ml aliquots of nonbacteriostatic saline. The
resulting lavage was used for P. aeruginosa culture and 16S rRNA analysis. Blind
mini-BAL and EA samples were centrifuged and stored at 80°C. Clinical data
were collected from patients’ charts and recorded in an Access database so that
severity of illness could be correlated with 16S rRNA data. Antibiotic drug
history was also recorded. All protocols were approved by the Committee on
Human Research of UCSF.
DNA extraction and amplification of the bacterial 16S rRNA gene. Bacterial
genomic DNA was isolated from 0.5 ml of EA and BAL samples with the
Promega (Carlsbad, CA) Wizard genomic DNA purification kit, according to the
manufacturer’s instructions for purification of both gram-negative and gram-
positive bacteria. The 16S rRNA gene was amplified from extracted DNA with
the universal bacterial primers Bact-27F (5-AGAGTTTGATCCTGGCTCAG-
3) and Bact-1492R (5-GGTTACCTTGTTACGACTT-3) (22). The reaction
mixture (50 l, final volume) contained 5 l of 10 PCR buffer (Amersham, NJ),
1 l of deoxynucleoside triphosphates (10 mM), 0.7 l of forward primer and
reverse primer (100 pmol/l each), 0.35 l of Taq polymerase (5 U/l; Amer-
sham), and 1 l of template DNA. PCR was performed with the DNA Engine
Tetrad thermal cycler (Bio-Rad). To maximize the number of bacterial species
that could be recovered by PCR, three different annealing temperatures (48°C,
52°C, and 56°C) were used for each sample to amplify the 16S rRNA genes. The
following cycling parameters were used: 3 min of initial denaturation at 95°C
followed by 25 cycles of denaturation (30 s at 95°C), annealing (30 s), and
elongation (120 s at 72°C), with a final extension at 72°C for 7 min. Amplified
products from all samples were verified by gel electrophoresis. All PCR products
were gel purified with the QIAquick gel extraction kit (QIAGEN), and, for each
sample, the purified products amplified at three different annealing temperatures
were pooled for cloning, sequencing, and microarray analysis.
Cloning and sequencing. To generate libraries for each sample, the respective
full-length 16S RNA PCR products were cloned into pCR4-TOPO vectors (In-
vitrogen) according to the manufacturer’s instructions. One hundred ninety-two
transformants from each library were picked randomly. Double-ended sequenc-
ing reactions of the entire 16S RNA sequence were carried out with PE BigDye
terminator chemistry (Perkin Elmer) and resolved with an ABI PRISM 3730
(Applied Biosystems) capillary DNA sequencer. Sequencing was performed at
the DOE Joint Genome Institute.
Sequence alignment and phylogenetic analysis. Paired-end sequencing reads
of 16S rRNA clones were assembled with Phrap (12, 13), and only clones in
which 80% of the bases had quality scores of at least Phred 20 (indicating a
probability of error of 1%) were included in the analysis. Chimeric sequences
were then detected with an online tool at Greengenes (8) (http://greengenes.lbl
.gov) by using an updated version of Bellerophon (19) and were also excluded
from the analysis. For the 19 samples we report here, an average of 90% of
sequenced clones met these criteria and were included in subsequent analyses.
Sequences were aligned to the Greengenes 7,682-character format with the
NAST (9) web server prior to being assigned to a taxonomic node with a sliding
scale of similarity thresholds (34) and the Greengenes classifying tool. Distance
matrices were constructed for each library with the distance matrix tool at
Greengenes, with NAST-aligned sequence data as input.
Phylotype clustering and diversity estimates. Using the distance matrices
generated, numbers of 16S rRNA gene phylotypes were calculated at 99%
sequence identity with the furthest neighbor clustering in the program DOTUR
(33), with 1,000 iterations for bootstrapping. A representative 16S rRNA gene-
based phylogenetic tree was constructed with the software package ARB (32)
using data from the Greengenes database. Microbial diversity was estimated with
the Shannon diversity index (H). This index takes into account both the number
of species present and the proportion of the total accounted for by each species,
increasing with species number and greater unevenness of species prevalence
(11, 15, 23). The number of species present and the diversity index were com-
pared with the nonparametric Wilcoxon signed-rank test for paired samples.
PhyloChip processing, scanning, probe set scoring, and normalization. The
pooled PCR product was spiked with known concentrations of synthetic 16S
rRNA gene fragments and non-16S rRNA gene fragments as internal standards
for normalization, with quantities ranging from 5.02  108 to 7.29  1010
molecules applied to the final hybridization mix. Target fragmentation, biotin
labeling, PhyloChip hybridization, scanning, and staining were as described by
Brodie et al. (3), while background subtraction, noise calculation, and detection
and quantification criteria were essentially as previously reported (3), with some
minor exceptions. For a probe pair to be considered positive, the difference in
intensity between the perfect match (PM) and mismatch (MM) probes must be
at least 130 times the squared noise value (N). A taxon was considered present
in the sample when 90% or more of its assigned probe pairs for its corresponding
probe set were positive (positive fraction, 0.90). Hybridization intensity (re-
ferred to as intensity) was calculated in arbitrary units for each probe set as the
trimmed average (maximum and minimum values removed before averaging) of
the PM minus MM intensity differences across the probe pairs in a given probe
set. All intensities of 1 were shifted to 1 to avoid errors in subsequent loga-
rithmic transformations. To account for scanning intensity variations from array
to array, the intensities resulting from the internal standard probe sets were
natural log transformed. Adjustment factors for each PhyloChip were calculated
by fitting a linear model by the least-squares method. A PhyloChip’s adjustment
factor was subtracted from each probe set’s lnintensity. Intensities for patient 1
were also normalized by total array intensity. When summarizing PhyloChip
results to the subfamily, the taxon with a probe set producing the highest inten-
sity within a subfamily was used.
Nucleotide sequence accession numbers. The nucleotide sequences generated
in this study have been submitted to the GenBank database under accession
numbers EF508731 to EF512008.
RESULTS
We began our study by comparing sampling techniques. To
do this, the bacterial species compositions of samples obtained
with blind mini-BAL were compared to those obtained with
EAs from two patients with hospital-acquired P. aeruginosa by
using 16S rRNA clone library sequencing. While there were
distinct differences in community compositions between these
two patients, the community compositions of the EA and BAL
samples from each individual were highly similar (Fig. 1A and
B). Therefore, in the remainder of this study, EAs were used
due to the simplicity and cost-effectiveness of this less-invasive
sample collection method.
Next, as a control for this study, EA samples were collected
from three healthy individuals who had been briefly intubated
for elective surgery. No 16S rRNA PCR product was detected
from these patients (data not shown) under the conditions that
readily yielded 16S rRNA amplicons in study patients, con-
firming that the normal lung is sterile and that our techniques
identify organisms present only after colonization of the endo-
tracheal tube and airway has occurred.
We next collected EAs from seven patients colonized by
Pseudomonas aeruginosa. Patient age, sex, timing of EA sam-
pling, periods of antibiotic administration, and antibiotic sen-
sitivity details are presented in Table 1. All patient samples
yielded a 16S rRNA PCR product, and a total of 3,278 non-
chimeric 16S rRNA sequences from patient-derived 16S librar-
ies were subjected to phylogenetic analysis. Almost all organ-
isms detected by cloning and sequencing were from five
bacterial phyla, the Firmicutes, Bacteroidetes, Proteobacteria,
Actinobacteria, and Fusobacteria (Fig. 1C). Over half (55%) of
the sequences obtained were from Pseudomonas aeruginosa,
followed by Stenotrophomonas maltophilia (9.7%), Prevotella
spp. (5.8%), Acinetobacter spp. (5.7%), Serratia marcescens
(5.0%), Haemophilus spp. (3.8%), Neisseria spp. (3.3%), My-
coplasma spp. (2.4%), and Streptococcus spp. (2.3%). An ad-
ditional18 genera were detected but together represented less
than 7% of all clones sequenced. Of these less-abundant spe-
cies, many are known oral, nasal, and gastrointestinal tract
inhabitants, e.g., Porphyromonas, Campylobacter, Fusobacterium,
Lactobacillus, Enterococcus, Rothia, Actinomyces, Abiotrophia,
Alcaligenes, Corynebacterium, Staphylococcus, and Veillonella
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FIG. 1. (A and B) Comparisons of 16S rRNA clone libraries of EA (white bars) and BAL (black bars) patient samples. (A) A total of 173 clones were
sequenced from the EA samples, and 153 clones were sequenced from the BAL samples. (B) A total of 154 clones were sequenced from the EA samples,
and 141 clones were sequenced from the BAL samples. Species abundances (as percentages) of the sequenced clones are indicated above the bars.
(C) Phylogenetic tree showing all recognized bacterial phyla/divisions. Phyla detected in EAs by cloning and PhyloChip microarray analyses are shown.
The five main phyla detected by clone library are indicated. Many additional phyla, undetected by cloning, were detected by array analysis.
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(6, 10, 27, 39). These results support the hypothesis that oral,
nasal, and gastrointestinal tract microbiota are the major res-
ervoirs for bacteria that colonize the lower airway in intubated
patients (17, 40, 41).
We next evaluated the bacterial diversity in five patients
(Table 1, patients 1 to 5) for whom an initial sample was
obtained within 24 h of parenteral antibiotic administration
and a second sample was obtained 4 to 10 days later. Analysis
of microbial diversity in the 16S clone libraries demonstrated a
substantial reduction in bacterial diversity during antibiotic
administration (Fig. 2). The mean number of bacterial species
identified fell from 16.2 to 5.6 (P  0.05), and Shannon’s
diversity index, a commonly used measure of microbial diver-
sity, fell from 1.48 to 0.59 (P  0.05). In each case, antibiotic
therapy led to selection of a pathogenic species that dominated
the community. In four of five patients, P. aeruginosa came to
dominate the microbial community at the second time point,
despite the administration of antibiotics to which it was sus-
ceptible in vitro (Table 1). In the fifth patient, the community
became dominated by another pathogen, Klebsiella pneu-
moniae. Even when P. aeruginosa constituted the majority of
the population at the initial time point, as in patient 3, who was
chronically ventilated, there was initial diversity in the remain-
der of the community that was lost with antibiotic therapy.
To investigate how the bacterial community changed over a
longer period of antibiotic treatment, we obtained additional
samples at later time points for two patients (patients 2 and 5),
and during prolonged antibiotic therapy in two additional pa-
tients (patients 6 and 7). All of these samples showed reduced
diversity compared with the initial time point, and P. aerugi-
nosa was the predominant species in six of seven samples,
suggesting that once this organism is established as the domi-
nant species, microbial diversity is slow to recover. Patient 2
did demonstrate a reduction in the relative abundance of P.
aeruginosa following adjustment of antipseudomonal therapy
11 days after colonization, and, importantly, this was accom-
panied by substantial recovery of microbial diversity. This pa-
tient improved clinically, and extubation was attempted. Col-
lectively, these data demonstrate that the loss of bacterial
diversity and Pseudomonas dominance are highly correlated
during antipseudomonal therapy.
Dominance of bacterial communities by one or a few species
may result either from overgrowth of the dominant species or
from loss of the nondominant species. Due to the limited
number of clones that can feasibly be sampled from clone
libraries, highly abundant species may mask the presence of
less-abundant but clinically significant species. To determine
whether the decline in diversity observed in clone libraries was
TABLE 1. Patient information and antimicrobial treatment
Patient
No. of days after
enrollment
(sample no.)
Sex Patient age
Antimicrobial treatment
Within 24 h before study enrollment Following sampling (sensitivitya)
1 1 (1) Female 57 yr Cefazolin, piperacillin-tazobactam Piperacillin-tazobactam (S), fluconazole,
cefazolin
7 (2) Cefazolin (S), fluconazole (S), levofloxacin (S)
2 1 (1) Male 79 yr Cefazolin, ceftazidime Antifungal, ceftazidime (S), vancomycin
11 (2) Ceftazidime (R), vancomycin, piperacillin-
tazobactam (S), ciprofloxacin (S)
15 (3) Vancomycin, piperacillin-tazobactam,
ciprofloxacin
3 1 (1) Female 54 yr None Ciprofloxacin (S)
5 (2) Ciprofloxacin
4 1 (1) Male 55 yr None Piperacillin-tazobactam, vancomycin
7 (2) Piperacillin-tazobactam
5 1 (1) Female 85 yr Clindamycin Clindamycin, piperacillin-tazobactam (S)
4 (2) Piperacillin-tazobactam (S), vancomycin,
ciprofloxacin (S)
15 (3) None
18 (4) None
23 (5) None
6 1 (1) Female 45 yr None Meropenem (I), fluconazole, linezolid
23 (2) Tobramycin(S), imipenem (I), cefpirome,
cefazolin, cefepime (I)
102 (3) Timentin, trimethoprim-sulfamethoxazole,
imipenem, vancomycin, fluconazole,
cefepime, cefpirome, amphotericin B,
tobramycin
7 1 (1) Female 2 mo Ampicillin, gentamicin,
trimethoprim-sulfamethoxazole
Ampicillin (R), gentamicin
82 (2) Gentamicin (S)
a S, sensitive; R, resistant; I, indeterminate.
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a true reflection of the bacterial community in these patients,
bacterial diversity was also analyzed with high-density microar-
rays (PhyloChips), which have enhanced sensitivity for low-
abundance species compared with cloning (7). For four pa-
tients, the same 16S rRNA gene amplicon pools from which
clone libraries were prepared were subsequently hybridized to
PhyloChips, and the bacterial communities were compared
(Fig. 3). While the microarray approach detected 30 times
more bacterial types than did clone library sequencing (P 
0.0001), the PhyloChip data clearly mirrored the loss of diver-
sity found in the clone library data, with the mean number of
observed phylotypes falling from 517 to 280 during antibiotic
treatment (P  0.05). These data clearly show that the loss of
diversity demonstrated in clone libraries is not an artifact of
sampling and confirm that antibiotic treatment leads to lower
diversity.
Due to the great sensitivity of the PhyloChip, entire bacterial
community responses can be monitored by this technique.
Figure 4A illustrates temporal changes in the fluorescence
FIG. 2. Temporal changes in bacterial diversity. Each bar represents the color-coded relative abundance of bacteria in a single EA. Numbers above
the horizontal bars represent individual patients, and the numbers of clones analyzed for each sample are indicated directly above each bar. For each
sample, Shannon’s diversity statistic, which reflects both species numbers and evenness of species distribution, is plotted below the histogram.
FIG. 3. Comparison of PhyloChip and clone library monitoring of
bacterial diversity (phylotype numbers) over time for four patients.
Closed symbols show numbers of bacterial phylotypes detected by
PhyloChip analysis; open symbols show numbers of bacterial phylo-
types detected by clone library on a logarithmic scale. The PhyloChip
reveals many more bacterial groups, but the data exactly mirror the
loss of diversity revealed by clone library sequencing.
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FIG. 4. PhyloChip analysis of complete bacterial communities over time in EAs. (A) Bacteria are ordered alphabetically from left to right
according to taxonomic affiliation. Bars above the zero line represent bacteria that increased in abundance relative to the first EA sample being
compared; bars below represent those bacteria that declined in abundance. (B) Venn diagrams demonstrate the number of bacterial subfamilies
detected at each time point. Note the significant overlap in composition between successive time points.
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intensity of bacteria detected by PhyloChip. Bacteria demon-
strating large changes in intensity between time points are
labeled, and these correspond well to the dominant bacterial
species detected by clone library analysis. The dominance of a
few species within a community analyzed by 16S rRNA clone
library clearly reflects the limited number of clones sequenced.
The PhyloChip readily demonstrated that many bacteria
present at the initial sampling point were indeed still present in
the subsequent sampling period (Fig. 4B). Conversely, bacteria
such as Klebsiella that became dominant in later clone library
samples were detected in the initial sample by PhyloChip but
were not detected in the corresponding clone library. This
underscores the potential for low-abundance species to even-
tually dominate bacterial communities during the course of
antimicrobial administration.
The microarray analysis also allowed us to correlate changes
in phylogenetic groups over time when these groups of bacteria
respond in similar manners to antibiotic administration. For
example the -Proteobacteria (which include Pseudomonas
aeruginosa) generally exhibit an inverse relationship in abun-
dance with bacteria in the phylum Actinobacteria and in the
class Bacilli (which includes Lactobacillus, Streptococcus,
Staphylococcus, and Enterococcus) in all patients examined
(Fig. 4A). Similarly Haemophilus and Pseudomonas also dem-
onstrated an inverse relationship. The reciprocal changes in
these subgroups within the bacterial community suggest they
may be competing for similar niches in the endotracheal envi-
ronment or otherwise influencing each other’s growth.
DISCUSSION
Management of infections caused by P. aeruginosa is increas-
ingly difficult due to this bacterium’s metabolic versatility,
intrinsic antimicrobial resistance, and remarkable armory of
virulence factors. Clinically, treatment options are becoming
limited due to the rapid emergence of multidrug-resistant
strains, which are now estimated to account for up to 30% of
strains isolated from patients in nursing homes, hospitals, and
intensive care units (30). In this study, we used 16S rRNA-
based culture-independent methods to determine the effect of
antibiotic therapy on bacterial community dynamics in patients
colonized with P. aeruginosa. Compared to culture-based
methods, both clone library and microarray techniques have
often provided a richer picture of microbial diversity (3, 10,
44), and we found that to be true in this study. Prior to, or early
in, antibiotic therapy, the airways were colonized with a re-
markably wide array of oral, nasal, and gut flora that are
presumably aspirated into the lung around the endotracheal
tube.
Not unexpectedly, antimicrobial treatment had a pro-
nounced effect on bacterial community composition, with bac-
terial diversity falling in every case. In most cases, P. aeruginosa
began as a relatively small fraction of the observed species and
came to dominate the community despite the administration of
antibiotics to which it was sensitive in vitro. Alarmingly, patho-
genic species became dominant in every patient during anti-
biotic therapy, and both the loss of diversity and P. aeruginosa
dominance often persisted during prolonged antibiotic ther-
apy. When P. aeruginosa declined with antibiotic therapy after
becoming dominant (patient 2), there was a substantial recov-
ery in microbial diversity. In contrast, when P. aeruginosa was
replaced by a dominant pathogen (patient 4), diversity de-
clined. Together, our data demonstrate that loss of diversity is
highly correlated with pathogen selection in P. aeruginosa-
colonized patients who are treated with antibiotics. We hy-
pothesize that reduced microbial diversity under antibiotic se-
lection in the airways may contribute directly to pathogen
selection through the loss of microbial competition. This con-
cept is supported by the observation that the abundance of
specific organisms (notably Actinobacteria and Bacilli) always
appeared to change in a manner opposite that of P. aeruginosa.
It has long been hypothesized that the evolution of virulence
is related to the number and variety of bacterial species infect-
ing the host (4, 31). Previously, it was predicted that increased
diversity of pathogenic species would promote virulence of
individual species (31). However, more recently it has been
demonstrated that in polymicrobial infections, less-virulent
strains are often favored, suggesting that increased diversity
may in fact reduce virulence (21). This hypothesis is supported
by our observation that administration of antimicrobials elim-
inates competition by decreasing the diversity of nontarget
organisms and allowing an increase in pathogen abundance.
One mechanism through which a decrease in bacterial diversity
might alter virulence is quorum sensing. Quorum sensing is a
means of bacterial cross-talk between individual cells incorpo-
rated into a biofilm, and it may radically affect the gene ex-
pression and virulence of pathogens, including P. aeruginosa
(24, 25, 43). Further studies investigating the contribution of
bacterial dynamics to pathogenicity will be required to fully
evaluate this hypothesis.
This study highlights the importance of recognizing and
understanding the complex bacterial community dynamic
that exists in the airways of intubated patients and that is
routinely missed by traditional culture-based analyses.
Treatment strategies that rely primarily on the identification
of P. aeruginosa in the airways may often result in subopti-
mal clinical outcomes. Specifically, in our study, administra-
tion of antibiotics to patients colonized with P. aeruginosa
within a complex bacterial community led to loss of micro-
bial diversity and selection of P. aeruginosa or another
pathogen. In previous studies, strategies to minimize anti-
biotic use led to improved outcomes and the emergence of
fewer multidrug-resistant strains (5). While further study is
clearly needed, we believe that culture-independent surveil-
lance of microbial diversity could be a useful adjunct in the
management of intubated patients colonized by P. aerugi-
nosa by helping to determine both the effectiveness and the
appropriate duration of antibiotic therapy.
We used two culture-independent methods in this study,
both of which showed qualitatively similar reductions in
bacterial diversity during antibiotic treatment. The Phylo-
Chip is clearly superior to clone library sequencing for as-
sessing the complete spectrum of bacteria present in the
community, including low-abundance species, while the 16S
rRNA library approach provides important information on
relative abundance at the species level. Both culture-inde-
pendent molecular methods documented a multitude of bac-
teria undetected by standard identification techniques. Im-
portantly, this was true not only for fastidious, slow-growing,
and/or unculturable organisms but also for routinely cul-
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tured pathogens (3, 10, 44). Unlike sequencing, the Phylo-
Chip method does not require cloning and is therefore rapid
enough that it could be used to provide information about
bacterial abundance and diversity in the clinical setting.
In summary, we have documented the evolution of the com-
plex bacterial community that exists in intubated patients, who
are often subjected to a variety of antibiotics. Our data indicate
that P. aeruginosa frequently arises to become the dominant
organism in colonized patients, as competing flora are elimi-
nated by antimicrobial therapy. This may occur even when the
patient is on appropriate antipseudomonal therapy as indi-
cated by the in vitro susceptibility profile. If bacterial commu-
nity changes could be monitored in a timely and cost-effective
manner, the effectiveness of antimicrobial therapy might be
more readily judged. Furthermore, we hypothesize that this
methodology could be utilized to gauge the effectiveness of
antibiotic treatment and individualize the duration of antibi-
otic therapy, perhaps by treating only until microbial diversity
rebounds. Ultimately, culture-independent methods such as
the PhyloChip will need to be tested for the ability to help
guide antibiotic therapy and improve outcomes for intubated
patients.
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